Compound Detail

CHEMBL1814601

Enter ChEMBL ID:

Free Research Context This compound will appear in recent viewed items on the research home for this browser.

CC(C)COP(=O)(OCC(C)C)C(N=C=S)c1ccccc1

ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID	CHEMBL1814601
Phase	Preclinical
Structure Type	MOL
InChI Key	YWPYSDRUPRYCRD-UHFFFAOYSA-N

Targets

Activities

Assay Types

PK Parameters

Publications

Known Names

341.4

MW (Da)

5.33

ALogP

HBA

HBD

47.9

PSA (Å²)

0.35

QED

Ro5 Violations

Rot. Bonds

First in Class Prodrug

IC50 5 meas. best 4.99

Target	Type	Best pChEMBL	Mean pChEMBL	Best (nM)	# Data
T47D CHEMBL614361	IC50	4.99	4.99	10200.0	1
LoVo CHEMBL614721	IC50	4.99	4.955	10200.0	2
MCF7 CHEMBL387	IC50	4.92	4.92	11900.0	1
A549 CHEMBL392	IC50	4.76	4.76	17200.0	1

Top measurements by pChEMBL value

Target	Type	Rel.	Value	Units	pChEMBL	Assay	PubMed
T47D	IC50	=	10200.0	nM	4.99	Antiproliferative activity against human T47D cells after 72 hrs by SRB assay	21704523
LoVo	IC50	=	10200.0	nM	4.99	Antiproliferative activity against human LoVo cells after 72 hrs by SRB assay	21704523
MCF7	IC50	=	11900.0	nM	4.92	Antiproliferative activity against human MCF7 cells after 72 hrs by SRB assay	21704523
LoVo	IC50	=	11900.0	nM	4.92	Antiproliferative activity against doxorubicin-resistant human LoVo cells after ...	21704523
A549	IC50	=	17200.0	nM	4.76	Antiproliferative activity against human A549 cells after 72 hrs by SRB assay	21704523

PubMed	DOI	Target Context	# Activities
21704523	10.1016/j.bmcl.2011.05.113	A549	17
21704523	10.1016/j.bmcl.2011.05.113	LoVo	2
21704523	10.1016/j.bmcl.2011.05.113	T47D	1
21704523	10.1016/j.bmcl.2011.05.113	MCF7	1

Data from ChEMBL 36 via Core Engine